{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T00:59:21Z","timestamp":1769302761921,"version":"3.49.0"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T00:00:00Z","timestamp":1676937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Hepatoblastoma (HB) is the most common primary liver cancer in children with emerging evidence that incidence is increasing globally. While overall survival for low risk hepatoblastoma is &amp;gt;90%, children with metastatic disease have worse survival. As identifying factors associated with high-risk disease is critical for improving outcomes for these children, a need for a further understanding of the epidemiology of hepatoblastoma is warranted. Therefore, we conducted a population-based epidemiologic study of hepatoblastoma in Texas, a large state characterized by ethnic and geographic diversity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Information on children diagnosed with hepatoblastoma at 0\u201319 years of age for the period of 1995\u20132018 was obtained from the Texas Cancer Registry (TCR). Demographic and clinical variables including sex, race\/ethnicity, age at diagnosis, urban-rural status, and residence along the Texas-Mexico border were evaluated. Multivariable Poisson regression was used to calculate adjusted incidence rate ratios (aIRRs) and 95% confidence intervals (CIs) for each variable of interest. Joinpoint regression analysis was used to determine the trend in incidence of hepatoblastoma, overall and by ethnicity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Overall, 309 children diagnosed with hepatoblastoma in Texas for the period of 1995\u20132018. Joinpoint regression analysis showed no joinpoints in the overall or the ethnic-specific analyses. Over this period, the incidence increased at 4.59% annually; with the annual percent change higher among Latinos (5.12%) compared to non-Latinos (3.15%). Among these children, 57 (18%) had metastatic disease at diagnosis. Factors associated with hepatoblastoma included male sex (aIRR = 1.5, 95% CI: 1.2\u20131.8, <jats:italic>p<\/jats:italic> = 0.002); infancy (aIRR = 7.6, 95% CI: 6.0\u20139.7, <jats:italic>p<\/jats:italic> &amp;lt; 0.001); and Latino ethnicity (aIRR = 1.3, 95% CI: 1.0\u20131.7, <jats:italic>p<\/jats:italic> = 0.04). Additionally, children living in rural areas were less likely to develop hepatoblastoma (aIRR = 0.6, 95% CI: 0.4\u20131.0, <jats:italic>p<\/jats:italic> = 0.03). While residence on the Texas-Mexico border association with hepatoblastoma approached statistical significance (<jats:italic>p<\/jats:italic> = 0.06) in unadjusted models, this finding did not remain significant after adjusting for Latino ethnicity. The two factors associated with being diagnosed with metastatic hepatoblastoma included Latino ethnicity (aIRR = 2.1, 95% CI: 1.1\u20133.8, <jats:italic>p<\/jats:italic> = 0.02) and male sex (aIRR = 2.4, 95% CI: 1.3\u20134.3, <jats:italic>p<\/jats:italic> = 0.003).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>In this large population-based study of hepatoblastoma, we found several factors associated with hepatoblastoma and metastatic disease. The reasons for a higher burden of hepatoblastoma among Latino children is unclear but could be due to differences in geographic genetic ancestry, environmental exposures, or other unmeasured factors. Additionally, it is notable that Latino children were also more likely to be diagnosed with metastatic hepatoblastoma compared to non-Latino white children. To our knowledge, this has not been previously reported and warrants further study to delineate the causes of this disparity and identify interventions to improve outcomes.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpubh.2023.1049727","type":"journal-article","created":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T05:05:32Z","timestamp":1676955932000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["A population-based assessment of metastatic hepatoblastoma in Texas reveals ethnic disparities"],"prefix":"10.3389","volume":"11","author":[{"given":"Andres F.","family":"Espinoza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael E.","family":"Scheurer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiffany M.","family":"Chambers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjeev A.","family":"Vasudevan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip J.","family":"Lupo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,2,21]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","DOI":"10.36255\/exonpublications.livercancer.2021.ch8","article-title":"Hepatoblastoma","volume-title":"Liver Cancer","author":"Hager","year":"2021"},{"key":"B2","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/S1470-2045(16)30598-8","article-title":"Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International Collaboration","volume":"18","author":"Meyers","year":"2017","journal-title":"Lancet Oncol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/cncr.23169","article-title":"Trends in childhood cancer incidence in the U","volume":"112","author":"Linabery","year":"2008","journal-title":"Cancer"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1093\/jncics\/pkz007","article-title":"Trends in international incidence of pediatric cancers in children under 5 years of age: 1988-2012","author":"Hubbard","year":"2019","journal-title":"JNCI Cancer Spectr"},{"key":"B5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/MOP.0000000000000046","article-title":"Hepatoblastoma state of the art: pathology, genetics, risk stratification, and chemotherapy","volume":"26","author":"Czauderna","year":"2014","journal-title":"Curr Opin Pediatr."},{"key":"B6","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/pbc.10376","article-title":"Liver transplantation for hepatoblastoma: results from the International Society of Pediatric Oncology (SIOP) study SIOPEL-1 and review of the world experience","volume":"42","author":"Otte","year":"2004","journal-title":"Pediatr Blood Cancer."},{"key":"B7","doi-asserted-by":"publisher","first-page":"150856","DOI":"10.1016\/j.sempedsurg.2019.150856","article-title":"Surgical management of locally-advanced and metastatic hepatoblastoma","volume":"28","author":"Lake","year":"2019","journal-title":"Semin Pediatr Surg."},{"key":"B8","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1002\/pbc.24215","article-title":"The epidemiology of hepatoblastoma","volume":"59","author":"Spector","year":"2012","journal-title":"Pediatr Blood Cancer."},{"key":"B9","year":""},{"key":"B10","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.jpedsurg.2017.03.017","article-title":"Vascular invasion is a prognostic indicator in hepatoblastoma","volume":"52","author":"Shi","year":"2017","journal-title":"J Pediatr Surg."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1016\/j.jpedsurg.2008.05.031","article-title":"Survival after liver transplantation for hepatoblastoma: a 2-center experience","volume":"43","author":"Browne","year":"2008","journal-title":"J Pediatr Surg."},{"key":"B12","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.ejca.2012.10.003","article-title":"Relapses in hepatoblastoma patients: clinical characteristics and outcome\u2013experience of the International Childhood Liver Tumour Strategy Group (SIOPEL)","volume":"49","author":"Semeraro","year":"2013","journal-title":"Eur J Cancer."},{"key":"B13","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1002\/pbc.20122","article-title":"Hepatoblastoma and low birth weight","volume":"43","author":"Spector","year":"2004","journal-title":"Pediatr Blood Cancer."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e5858","DOI":"10.1097\/MD.0000000000005858","article-title":"Hepatoblastoma in an 11-year-old: case report and a review of the literature","volume":"96","author":"Pateva","year":"2017","journal-title":"Medicine."},{"key":"B15","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/S0002-9343(99)00063-7","article-title":"Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis","volume":"106","author":"Grodstein","year":"1999","journal-title":"Am J Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s13287-016-0439-4","article-title":"Bile acid: a potential inducer of colon cancer stem cells","volume":"7","author":"Farhana","year":"2016","journal-title":"Stem Cell Res Ther."},{"key":"B17","doi-asserted-by":"publisher","first-page":"335","DOI":"10.4062\/biomolther.2018.103","article-title":"Sex differences in cancer: epidemiology, genetics and therapy","volume":"26","author":"Kim","year":"2018","journal-title":"Biomol Ther."},{"key":"B18","first-page":"1201","article-title":"Reproduction, endogenous and exogenous sex hormones, and colon cancer: a review and hypothesis","volume":"65","author":"McMichael","year":"1980","journal-title":"J Natl Cancer Inst."},{"key":"B19","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3389\/fgene.2012.00268","article-title":"Gender differences in cancer susceptibility: an inadequately addressed issue","volume":"3","author":"Dorak","year":"2012","journal-title":"Front Genet."},{"key":"B20","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1289\/ehp.95103s8283","article-title":"Racial, ethnic, and gender variations in cancer risk: considerations for future epidemiologic research","volume":"103","author":"Zahm","year":"1995","journal-title":"Environ Health Perspect"},{"key":"B21","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.mce.2009.02.015","article-title":"Sexual dimorphism in environmental epigenetic programming","volume":"304","author":"Gabory","year":"2009","journal-title":"Mol Cell Endocrinol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1111\/j.1582-4934.2011.01293.x","article-title":"On the role of autophagy in human diseases: a gender perspective","volume":"15","author":"Lista","year":"2011","journal-title":"J Cell Mol Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/S0149-7634(00)00027-0","article-title":"The effects of hormones on sex differences in infection: from genes to behavior","volume":"24","author":"Klein","year":"2000","journal-title":"Neurosci Biobehav Rev"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1158\/1055-9965.EPI-08-1118","article-title":"Sex disparities in cancer incidence by period and age","volume":"18","author":"Cook","year":"2009","journal-title":"Cancer Epidemiol. Biomarkers Prev"},{"key":"B25","volume-title":"Population Projections of the United States by Age, Sex, Race, and Hispanic Origin: 1995 to 2050, U.S. Bureau of the Census. Current Population Reports","author":"Day","year":"2017"},{"key":"B26","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s40880-019-0411-7","article-title":"Incidence trends and survival prediction of hepatoblastoma in children: a population-based study","volume":"39","author":"Feng","year":"2019","journal-title":"Cancer Commun."},{"key":"B27","doi-asserted-by":"publisher","first-page":"66","DOI":"10.20517\/2394-5079.2018.87","article-title":"Gender differences in hepatocellular cancer: disparities in nonalcoholic fatty liver disease\/steatohepatitis and liver transplantation","volume":"4","author":"Wu","year":"2018","journal-title":"Hepatoma Res."},{"key":"B28","volume-title":"Defining Rural at the U.S. Census Bureau","author":"Ratcliffe","year":"2016"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1158\/1055-9965.EPI-17-0430","article-title":"Rural-Urban differences in cancer incidence and trends in the United States","volume":"27","author":"Zahnd","year":"2018","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1200\/OP.22.00207","article-title":"Are quality cancer prevention and treatment along the Texas US-Mexico border achievable?","author":"Nodora","year":"2022","journal-title":"JCO Oncol Pract"},{"key":"B31","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1111\/hpb.12112","article-title":"Predictors of survival and incidence of hepatoblastoma in the paediatric population","volume":"15","author":"Allan","year":"2013","journal-title":"HPB."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e748","DOI":"10.1200\/OP.21.00431","article-title":"Disparities in guideline-concordant treatment and survival among border county residents with gastric cancer","volume":"18","author":"Ju","year":"2022","journal-title":"JCO Oncol Pract"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e770","DOI":"10.1200\/OP.22.00093","article-title":"Patterns of colorectal cancer in Texas counties from 2000 to 2017","volume":"18","author":"LaPelusa","year":"2022","journal-title":"JCO Oncol Pract"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2023.1049727\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T05:05:37Z","timestamp":1676955937000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2023.1049727\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,21]]},"references-count":33,"alternative-id":["10.3389\/fpubh.2023.1049727"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2023.1049727","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,21]]},"article-number":"1049727"}}